These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 21607331)
41. Cardiotoxicity of the antiproliferative compound fluorouracil. Becker K; Erckenbrecht JF; Häussinger D; Frieling T Drugs; 1999 Apr; 57(4):475-84. PubMed ID: 10235688 [TBL] [Abstract][Full Text] [Related]
42. Studies of hematopoietic stem cells spared by 5-fluorouracil. Van Zant G J Exp Med; 1984 Mar; 159(3):679-90. PubMed ID: 6699542 [TBL] [Abstract][Full Text] [Related]
43. Differential toxicity and pharmacokinetics of sodium and Tris salts of 5-fluorouracil in the rat. Plumb JA; Gardner ML Clin Sci (Lond); 1981 Jun; 60(6):707-10. PubMed ID: 7249549 [TBL] [Abstract][Full Text] [Related]
44. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats. Ganguly K; Kulkarni AR; Aminabhavi TM Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807 [TBL] [Abstract][Full Text] [Related]
45. Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice. Yu NY; Orenberg EK; Luck EE; Brown DM Cancer Chemother Pharmacol; 1995; 36(1):27-34. PubMed ID: 7720172 [TBL] [Abstract][Full Text] [Related]
47. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil]. Shirasaka T; Shimamoto Y; Kato T; Fukushima M Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831 [TBL] [Abstract][Full Text] [Related]
49. Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits. Lu DW; Chang CJ; Chiang CH; Yeh MK; Chou PI J Ocul Pharmacol Ther; 2000 Dec; 16(6):529-38. PubMed ID: 11132900 [TBL] [Abstract][Full Text] [Related]
50. Regional injection of 5-fluorouracil and starch microspheres in colorectal cancer. Ball AS; Mann CV; Clifton MA; Baker WN; Goode AW Acta Chir Scand; 1988 Sep; 154(9):521-4. PubMed ID: 3201864 [TBL] [Abstract][Full Text] [Related]
51. Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study. Fanciullino R; Giacometti S; Aubert C; Fina F; Martin PM; Piccerelle P; Ciccolini J Pharm Res; 2005 Dec; 22(12):2051-7. PubMed ID: 16222443 [TBL] [Abstract][Full Text] [Related]
53. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation. Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma. Kissel J; Brix G; Bellemann ME; Strauss LG; Dimitrakopoulou-Strauss A; Port R; Haberkorn U; Lorenz WJ Cancer Res; 1997 Aug; 57(16):3415-23. PubMed ID: 9270007 [TBL] [Abstract][Full Text] [Related]
55. [Stability of 5-fluorouracil solutions according to different parameters]. Barberi-Heyob M; Watelet M; Merlin JL; Bleger C; Schroeder B Bull Cancer; 1995 Dec; 82(12):1025-31. PubMed ID: 8745668 [TBL] [Abstract][Full Text] [Related]